Amphen, 200 Mg/G Granules For Use In Drinking Water For Pigs
Revised: June 2015
AN: 00138/2015 & 00141/2015
SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE VETERINARY MEDICINAL PRODUCT
Amphen, 200 mg/g granules for use in drinking water for pigs.
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Each g contains:
For a full list of excipients, see section 6.1
3. PHARMACEUTICAL FORM
Granules for use in drinking water.
White to cream waxy granules.
4. CLINICAL PARTICULARS
4.1 Target species
4.2 Indications for use, specifying the target species
For the treatment of swine respiratory disease associated with Pasteurella multocidasusceptible to florfenicol.
Do not administer to boars intended for breeding purposes.
Do not administer in cases of previous allergic reactions to florfenicol or any of the excipients.
Do not use in piglets less than 6 weeks old.
4.4 Special warnings for each target species
If there is no significant improvement after 3 days of treatment, the diagnosis should be reviewed and if necessary the treatment should be changed.
4.5 Special precautions for use
i) Special precautions for use in animals
The veterinary medicinal product should be used in conjunction with susceptibility testing. Official, national and regional antimicrobial policies should be taken into account when the product is used.
Inappropriate use of the veterinary medicinal product may increase the prevalence of bacteria resistant to florfenicol.
Treatment should not exceed 5 days.
ii) Special precautions for the person administering the veterinary medicinal product to animals
Avoid skin and eye contact with product.
Do not eat, drink or smoke when handling the product or mixing it with water.
Do not use in known cases of sensitivity to polyethylene glycols.
In case of accidental spillage onto skin rinse with water.
4.6 Adverse reactions (frequency and seriousness)
Diarrhoea has been very commonly reported (up to 30% of animals) and inflammation of the perianal area (up to 5 % of animals) has been commonly reported in treated animals. These effects are transient and normally resolve within 5 days. Rectal prolapse has been uncommonly reported.
A slight reduction in food consumption may be observed during treatment.
4.7 Use during pregnancy, lactation or lay
The safety of the product during pregnancy and lactation has not been demonstrated. Use of the product during pregnancy and lactation is therefore not recommended.
4.8 Interaction with other medicinal products and other forms of interaction
4.9 Amount(s) to be administered and administration route
Oral route in drinking water.
10 mg florfenicol /kg bodyweight per day in drinking water for 5 consecutive days.
The daily amount of product to be mixed with drinking water can be calculated based on the Total Body Weight (TBW) of the herd to be treated with the following formula:
Amount of product (in grams) per day*
Total Body Weight of the herd (TBW) in Kg
* to be mixed with the estimated total water consumption of the herd in 24 hr
The examples of medicated drinking water in the table below are calculated by applying the formula and by assuming that pigs drink 8% or 10% of their bodyweight.
TBW of the herd (Kg)
Estimated daily water consumption (L)
Product grams per 10 litres of water
Pigs drinking 8% of their bodyweight
Pigs drinking 10% of their bodyweight
FOR BULK TANK: To treat pigs drinking 10% of their bodyweight, at the dose of 10 mg/kg: add 5g product per 10L drinking water in the bulk tank and mix thoroughly until visually dissolved.
For pigs drinking 8% of their body weight, at a dose of 10mg/kg: add 6,25g product to every 10L drinking water in the tank and mix thoroughly until visually dissolved.
Any solutions for use in a header tank must be limited to no more than 2.5 g/L. Dissolution may take up to 30 minutes and solutions should be checked visually for complete dissolution.
FOR PROPORTIONER: Convenient proportioner settings for the use of florfenicol in the drinking water is 20%
To treat 5,000 kg of pigs, drinking 10% of their bodyweight, at the dose rate of 10 mg/kg:
1. Fill the proportioner with 100L drinking water.
2. Add 250g of product to the proportioner.
3. Mix thoroughly until visually dissolved
4. Set the proportioner to 20%.
5. Turn on the proportioner.
In order to ensure rapid dissolution, solutions should be prepared in accordance with the examples above. Otherwise, solutions should be visually inspected to ensure that dissolution is complete before the product is administered.
In order to ensure correct dosing and to prevent underdosing, the body weight of the herd should be calculated as precisely as possible and water consumption should be monitored. The required quantity of granules should be measured by suitably calibrated weighing equipment.
The uptake of water depends on several factors including the age, the clinical state of the animals and the local conditions such as ambient temperature and humidity. The daily water consumption can be underestimated (e.g. reduced to 6% of bodyweight) in order to ensure total consumption of medicated water during the day (fresh drinking water can be made available following the consumption of the medicated water). If it is not possible to obtain sufficient uptake of medicated water animals should be treated parenterally. The maximum solubility of the product granules is 5g/L at 20°C and 2.5 g/L at 9°C.
Medicated drinking water should be replaced every 24 hours.
4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
After administration at 3 times the recommended dose a reduction in food and water consumption, together with a decrease in bodyweight has been observed. After administration at 3 times or more of the recommended dose, depression of some animals have been observed.
4.11 Withdrawal period(s)
Meat and offal: 20 days
5. PHARMACOLOGICAL PROPERTIES
Pharmacotherapeutic group: Amphenicols
ATC Vet Code: QJ01BA90
5.1 Pharmacodynamic properties
Florfenicol is a synthetic, broad-spectrum antibiotic in the phenicol group active against most Gram-positive and Gram-negative organisms isolated from domestic animals. Florfenicol acts by inhibitingprotein synthesis at the ribosomal level and may beconsideredbacteriostatic.
However, bactericidal activity has been demonstrated in vitro against strains of Pasteurella multocida isolated from pigs and involved in respiratory disease.
Among clinical isolates collected from the respiratory tracts of swine between 2008-2010 in the EU, the observed florfenicol MIC50and MIC90were 0.25 – 1 µg/ml. For P. multocida the following breakpoints have been determined for florfenicol in swine respiratory disease; susceptibe: ≤ 2 µg/ml, intermediate: 4 µg/ml and resistant: ≥ 8 µg/ml (CLSI M31-A3, 2008).
Acquired resistance to florfenicol is associated with several genes, including FloR which encodes an efflux pump. Genes responsible for resistance are transferable by mobile genetic elements.
5.2 Pharmacokinetic properties
Following administration of florfenicol in drinking water for 5 consecutive days, the maximum plasma concentration of 3.92 µg/mL occurred at a median of 4 hours.
The mean plasma concentrations remained above 0.5 µg/mL for the 5 day administration period. The mean terminal half-life was 5.6 hours and mean AUC0-24 of 44.7 µg·h/mL. The major clearance mechanism is excretion in urine.
5.3 Environment properties
Florfenicol degrades in pig manure and in soil and as such will not persist in the environment.
6. PHARMACEUTICAL PARTICULARS
6.1 List of excipients
Macrogols (4000 and 400)
In the absence of compatibility studied this veterinary medicinal product must not be mixed with other veterinary medicinal products.
6.3 Shelf life
Shelf life of the veterinary medicinal product as packaged for sale: 4 years
Shelf life after first opening of the immediate packaging: 3 months
Shelf life after dilution or reconstitution according to directions: 24 hours
6.4 Special precautions for storage
This veterinary medicinal product does not require any special storage conditions.
Store in the original package.
6.5 Nature and composition of immediate packaging
Polyester/aluminium/polythene bags containing 0.5 kg, 1 kg or 5 kg of granules.
Not all pack sizes may be marketed.
6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products, if appropriate
Any unused veterinary medicinal product or waste material derived from such veterinary medicinal product should be disposed of in accordance with local requirements.
7. MARKETING AUTHORISATION HOLDER
8. MARKETING AUTHORISATION NUMBER
9. DATE OF FIRST AUTHORISATION
24 June 2013
10. DATE OF REVISION OF THE TEXT
Page 6 of 6